San Diego-based CareFusion Inc. is investing $100 million in Israeli pump maker Caesarea Medical Electronics, acquiring a 40 percent stake of the company.
HEALTH: Scripps, Kaiser, UC San Diego Have Plans For New Facilities
The completion of the $456 million Camp Pendleton Naval Hospital and the $225 million Scripps Proton Therapy Center highlighted a year in which several medical facilities, large and small, made strides toward opening.
BIOTECH: Strategic Reprioritization Reduces Amount for M&A Activity
Volcano Corp. has authorized a $200 million share repurchase program — an initiative in line with advice from an activist investor who is reportedly grooming the company as an acquisition target.
FINANCE: Local Biotech IPOs Were Market Forces in 2013
This has been a banner year for the life sciences initial public offering. Despite a recent downtick in IPO activity, San Diego has been a national leader in biotechnology and medical device companies going public this year.
MEDICINE: Is First California Organization to Join the System
Palomar Health will be the first in California to join the Mayo Clinic Care Network, a group of about two dozen hospitals that are affiliated with the prestigious Mayo Clinic and can tap its resources.
Palomar Health will join the Mayo Clinic Care Network, the Escondido-based health system announced Wednesday.
San Diego-based cancer drug developer Ignyta Inc. has raised $54 million in two separate stock offerings, exceeding the company’s original target of $35 million.
Volcano Corp. has authorized a $200 million share repurchase program — which is in line with the advice from an activist investor who is reportedly grooming the company as an acquisition target.
ENERGY: Program Is First in Nation, May Also Generate Revenue
The city of San Diego has a plan to reduce what it spends for electricity to power its streetlights — and maybe generate revenue in the process.
Biotech/Health Care Column
One of the 11 recipients of Bill Gates’ call to build the better condom goes to a Mira Mesa-based company, which posits that a prophylactic crafted from beef tendons could be a market winner.